Compare · CHE vs PRVA
CHE vs PRVA
Side-by-side comparison of Chemed Corp (CHE) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.15B, about 2.1x PRVA ($2.99B).
- Over the past year, CHE is down 25.4% and PRVA is up 2.7% - PRVA leads by 28.1 points.
- CHE has been more active in the news (6 items in the past 4 weeks vs 2 for PRVA).
- PRVA has more recent analyst coverage (25 ratings vs 6 for CHE).
- Company
- Chemed Corp
- Privia Health Group Inc.
- Price
- $421.57+9.84%
- $23.84+1.40%
- Market cap
- $6.15B
- $2.99B
- 1M return
- +12.75%
- +15.98%
- 1Y return
- -25.40%
- +2.67%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 6
- 2
- Recent ratings
- 6
- 25
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest CHE
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports First-Quarter 2026 Results
- Chemed Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
- SEC Form DEFR14A filed by Chemed Corp
- SEC Form DEF 14A filed by Chemed Corp
- Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24
- Roto-Rooter Completes Acquisitions for Two Significant Territories
- SEC Form 4 filed by Mcnamara Kevin J
- Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor
Latest PRVA
- Privia Health to Report First Quarter 2026 Results on Thursday, May 7
- SEC Form 4 filed by Mountcastle David
- SEC Form DEFA14A filed by Privia Health Group Inc.
- SEC Form DEF 14A filed by Privia Health Group Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Privia Health Group Inc.
- Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence
- SEC Form 4 filed by Mountcastle David
- SEC Form 4 filed by Mehrotra Parth
- EVP & Chief Financial Officer Mountcastle David sold $282,600 worth of shares (13,018 units at $21.71), decreasing direct ownership by 5% to 226,804 units (SEC Form 4)
- Chief Executive Officer Mehrotra Parth sold $1,172,078 worth of shares (53,992 units at $21.71), decreasing direct ownership by 8% to 581,952 units (SEC Form 4)